Tobias Meischl

11PUBLICATIONS
27CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Rehabilitation engineeringTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 01, 2026
Summative Comorbidities Are Independently Associated With Mortality in Patients With Hepatocellular Carcinoma.

|May 07, 2025
Non-Invasive Stratification of Portal Hypertension in Patients With BCR::ABL1-Negative Myeloproliferative Neoplasms.

Lorenz Balcar, Lina Degenfeld-Schonburg, Can Hopp

|Jul 11, 2024
Evolution of liver function during immune checkpoint inhibitor treatment for hepatocellular carcinoma.

Katharina Pomej, Lorenz Balcar, Sabrina Sidali

|Aug 25, 2023
Augmentation Therapy for Severe Alpha-1 Antitrypsin Deficiency Improves Survival and Is Decoupled from Spirometric Decline-A Multinational Registry Analysis.

Daniel D Fraughen, Auyon J Ghosh, Brian D Hobbs

|Apr 07, 2023
Early changes in immunoglobulin G levels during immune checkpoint inhibitor treatment are associated with survival in hepatocellular carcinoma patients.

Lorenz Balcar, David Bauer, Katharina Pomej

|Dec 08, 2021
Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib.

Katharina Pomej, Lorenz Balcar, Bernhard Scheiner

Pageof 2

Frequent Collaborators

5 joint publications

Katharina Pomej

5 joint publications

Thomas Reiberger

5 joint publications

Lorenz Balcar

4 joint publications

Matthias Pinter